Learning Objectives
By the end of this activity, the participant should be better able to:
| Review the underlying mechanisms of uric acid production and crystal deposition disease progression | |
| Identify the common comorbidities associated with patients with advanced gout and barriers to achieving successful management in those with monosodium urate crystal deposition | |
| Assess current treatment options, including safety and efficacy, in patients with chronic and advanced disease | |
| Develop and apply a practical, comprehensive and individualized management strategy for patients with advanced and refractory crystal deposition, taking into consideration new and emerging therapies |